Literature DB >> 24339456

An update on oral human papillomavirus infection.

Ankit H Bharti1, Kiran Chotaliya, Y S Marfatia.   

Abstract

Human papillomavirus (HPV) constitutes the majority of newly acquired sexually transmitted infections (STIs) in United States as per the centers for disease control factsheet 2013. Genital HPV is the most common STI with incidence of about 5.5 million world-wide, nearly 75% of sexually active men and women have been exposed to HPV at some point in their lives. Oral Sexual behavior is an important contributor to infection of HPV in the oral mucosa especially in cases known to practice high risk behavior and initiating the same at an early age. HPV infection of the oral mucosa currents is believed to affect 1-50% of the general population, depending on the method used for diagnosis. The immune system clears most HPV naturally within 2 years (about 90%), but the ones that persist can cause serious diseases. HPV is an essential carcinogen being implicated increasingly in association with cancers occurring at numerous sites in the body. Though there does not occur any specific treatment for the HPV infection, the diseases it causes are treatable such as genital warts, cervical and other cancers.

Entities:  

Keywords:  Human papillomavirus; oral human papillomavirus; oral infection

Year:  2013        PMID: 24339456      PMCID: PMC3841675          DOI: 10.4103/0253-7184.120533

Source DB:  PubMed          Journal:  Indian J Sex Transm Dis AIDS        ISSN: 2589-0557


INTRODUCTION

Human papillomavirus (HPV) constitutes the majority of newly acquired sexually transmitted infections (STIs) in United States as per the centers for disease control factsheet 2013. There are nearly 20 million new STI every year, of this HPV is the most common sexually transmitted virus and infection in the United State.[1] There are nearly 200 different strains of HPV, most of which are harmless and more than 40 HPV types that can infect genital and oral mucosa in both males and females, out of all these, 9 are known to cause cancers. Every day in the US, about 12,000 people ages 15-24 are infected with HPV.[2] The vast majority of them will clear the virus naturally and never know that they were exposed or had it. Sexual partners who have been together for a while tend to share HPV. This means that the partner of someone who tests positive for HPV likely has HPV already, even though they may have no signs or symptoms. Like most Americans, their immune system will clear it in under 2 years. India has one of the world's highest incidence of oral cancer. The major limitation of the current review was a dearth of adequate HPV related data in Indian population, which can establish precise facts and help to plot a strategy for its management and verify the role of HPV in the head and neck squamous cell carcinoma (HNSCC).

VIROLOGY

HPV is a 55 nm deoxyribonucleic acid (DNA) virus, which belongs to papillomaviridae family.[3456] The virion consist of a non-enveloped, singular double stranded DNA with nearly 5500 nucleotide base paires.[7] More than 120 genotypically different forms, with each type having nearly 90% of them sharing a similar DNA base pair homology.[8] Nearly 40 HPV types are known to infect the genital tract mucosa and 14 are detected in the majority of biopsies, of invasive cervical carcinoma and are therefore considered “high risk” [Table 1] or “oncogenic.”[1]
Table 1

HPV genotypes and oncogenic risk

HPV genotypes and oncogenic risk

IMUNOPATHOGENESIS

The precise mechanism of entrance of HPV into the cell are not yet validated. It is known that the HPV capsid proteins play an essential role in host epithelial cell entry and delivery of the viral DNA to the nucleus.[9]

HPV CLEARANCE

Acquiring new HPV infection is now strongly being associated with sexual behavior with female and male sexual partners. So is the probability of clearing existing HPV infection is also being strongly associated with sexual behavior. No association has been found with age and incidence of any, oncogenic, or non-oncogenic HPV types, although the probability of clearing these infections increased with age. The risk of HPV infection decreases with increasing age in women,[1011] men on the other hand seem to have a constant risk for acquiring new HPV infections throughout their life.[12] A study of men in the USA, noted that the incidence of HPV infection was constant over the age range 18-44 years.[13] and yet another study, claims that the incidence was constant in men aged 18-70 years and residing in Brazil, Mexico and USA.[12] Markowitz et al. reported faster clearance of oncogenic HPV infections in men with increasing age.[12] thus more rapid clearance noted in older men might be related to a higher prevalence of HPV antibodies in older men.[14] In consensus to what has been reported in women, the median time to clearance of HPV 16 is nearly 2 times longer (about 12 months) than with other oncogenic HPV types (e.g. 6·3 months for HPV 18). Clearance of specific HPV types by age group needs to be further assessed in Indian population especially by meta-analysis studies. The median time for clearance of any type of HPV infection was significantly longer in men aged 18-30 years as compared to other age groups.[12]

TRANSMISSION

HPV infection of oral and oropharyngeal mucosa are associated with oro-genital sex and high risk sexual behavior of cohabiting numerous partners, particularly when initiated at an early age.[1516171819] HPV infection is more strongly related to couples who practiced oral sex as against couples who solely practiced vaginal sex.[1720] Oral and oropharyngeal HPV infections are primarily acquired through sexual activities, mouth to mouth contact between partners or family members, autoinoculation and vertical transmission during birth are also some of the known routes which can establish HPV infection.[172122] Mucosotropic HPV strains are capable of causing benign lesions in the upper aerodigestive tract.[23]

CLINICAL MANIFESTATIONS

Focal epithelial hyperplasia (heck disease)

Heck's disease or focal epithelial hyperplasia was first described in 1965, it is seen most commonly in Alaska Eskimos and in American native or Indians, South Africa and occasionally in Israel. It affects oral mucosa, lips, tongue, notably lower lip and more rarely the palate, floor of the mouth and oro-pharynx more commonly in the age group of 3-18, but can be seen in all age groups.[24] It is strongly associated with HPV types 13 and 32 which are seen in about 90% of infections.[2526] Usually regresses spontaneously but treatment is often taken to mitigate esthetic problems or repeated bite injuries.

Oral squamous papilloma

Oral Squamous papilloma is a benign tumor se en in all age groups, more commonly in 30-50 years of age. The lesions in children are commonly seen in the laryngotracheobronchial complex and in the oral mucosa over soft palate, lingual, frenulum, lower lip and uvula among adults.[24] It is mainly related to HPV 6 and 11. Surgical removal is the first choice of treatment, but electrocauterization, cryosurgery and interferon injections are also used.

Oral condyloma acuminata

Condyloma is derived from the Greek word “kondilus” i.e. round tumors and acuminatum from the Latin word “acuminare”; i.e. to become pointed. The sexual route remains the main route of transmission (20%)[27] and people who have oral sex have a 50% chance to acquire the oral infection. Incubation period ranges from 2 to 8 weeks. It is characterized by little pinkish or whitish nodules, which proliferate over tongue, lips, palate and floor of mouth which can be sessile or pedunculated. The surface contour is usually cauliflower like. HPV types 6 and 11 have commonly been detected with immunohistochemistry and by hybridization with 75-85% positivity.[2829]

Common warts (Verruca vulgaris)

Verruca vulgaris is one of the most common manifestation seen mainly in children can infect oral mucosa.[24] It is usually seen on lips, hard palate, gingival and dorsal surface of tongue. The most common HPV types affecting the musocostrofics (6, 11 and 16) and the cutaneoustrofic (1, 2, 4 and 7) and HPV-2 and HPV-4 are detected in more than 55% of oral lesions.[30] Usually warts are self-limited and resolve within 2 years. Treatment is sought usually because of esthetic discomfort or to avoid bite injuries.

Oral lichen planus

OLP chronic immunomediated disease with unknown etiology, which is seen commonly in relation with skin and mucosal lesions associated with HPV.[3132] It is commonly seen in age group of 30-60 years predominantly in females, though it can also be seen in children and adolescents. The lesions of OLP are generally bilateral and symmetrical, affects the oral mucosa, gingival, the dorsum of tongue and lip mucosa. HPV types 11 and 16 are commonly found in about 87% of patients. Treatment with corticosteroids reduces the symptoms but does not cure the condition, treatment with calcineurin inhibitors, topical retinoids are also used as additive therapy.[3334]

Oral verrucous carcinoma

A variant of squamous cell carcinoma (SCC), which is benign with well-distinguished morphology and clinical presentation. It is a rare tumor described by Ackerman in 1948 as a cancer that commonly involves lips, oropharynx and laryngeal mucosa. It is also known as Acherman's tumor, florid papilomatosis, epithelioma cuniculatum and carcinoma cuniculatum[35] and Buschke – Loewestein. Commonly caused by HPV types 6, 11, 16 and 18.[24] The treatment of choice is surgical resection, Radiotherapy with resection, cytostatic drugs like interferon – α. Recurrence rate is high when isolated surgical resection or radiotherapy is performed.[35]

Oral leukoplakia

Martorell-Calatayud A. described oral leukoplakia as “a white patch or plaque that cannot be characterized clinically or histologically as any other disease.” It is considered to be premalignant lesion of oral cavity and has a potential of 16-62% of getting converted into oral SCC.[36] Oral leukoplakia is commonly caused by HPV types 6, 11 and 16.[37] No consensus as to the best treatment course and prevention remains the best approach. Non-surgical treatment based on topical bleomycin and systemic retinoids. Invasive treatment includes cryosurgery, CO2 laser and surgical resection. They are effective in the short run, nut lesions may relapse in the long run.

Oral squamous cell carcinoma

In 1976, the first description of relation between OSCC and HPV was described by Zur Hausen, since then it has been as an exclusive cause for Cervical Carcinoma.[31] HPV was seen in association to 20% of OSCC cases as reported in 1983 by Syrjanen.[38] HNSCC are a major cause of morbidity and mortality world-wide especially in the Indian subcontinent with > 90% of which are SCC and rank sixth among all malignancies worldwide.[39] More than 90% HNSCC and anogenital cancers are caused by HPV-16 type. It represents 3% of malignant transformation, i.e. more than 5,000 diagnosed cases a day and more than 90% of oral cancers. HPV infection influences the prognosis of the SCC [Table 2]. The similarities between the oral and genital injuries along with the following factors point toward a role of HPV infection in oral mucosa, i.e. Affinity to epithelial cells, type of genital and oropharyngeal epithelia and oncogenic potential of HPV.[40]
Table 2

Difference between oropharyngeal cancer HPV+ and HPV–

Difference between oropharyngeal cancer HPV+ and HPV

Recurrent respiratory papillomatosis

It is characterized by the proliferation of benign squamous papillomas within the aerodigestive tract.[414243] In 75% of children with RRP, the diagnosis was made before the child's 50th birthday and in adults in fourth decade.[44] It is mainly caused by HPV-6 and HPV-11, found usually over oral mucosa, trachea and bronchi and esophagus. In 1998, Wang et al. reported this disease presenting in age < 5 years it is referred as Juvenile Onset RRP is thought to be vertically transmitted during the childbirth, although transplacental transmission has also been reported.[45] Treatment modalities include cold steel excision, CO2 laser and adjuvant modalities such as interferon, ribavarin, cidofovir, photodynamic therapy, HPV vaccine etc.

WHIM syndrome

It is a rare Autosomal Dominant syndrome characterized by warts, hypogammaglobulinemia, infections and retention of mature neutrophils in the bone marrow (myelokathexis) also associated with increased susceptibility to HPV infections is also reported. The occurrence of HPV related SCC in two sibling with WHIM syndrome was reported by Cipriani et al. A mutation in chemokine receptor CXCR4, a 7-transmembrane protein expressed in a variety of stem cells and progenitor cells, but its role is not well-characterized.[46]

RELATION TO HUMAN IMMUNODEFICIENCY VIRUS

Sikora et al. proved that seropositive individuals show a higher prevalence of oral infection with high oncogenic risk HPV, which increase with age, male gender and infection by Virion Host Shutoff – 2 protein.[29] Seropositive individuals also have a higher risk of getting oral HPV infection from more than one HPV types, further increasing the oncogenic potential of the infection.[21] The risk of infection by high oncogenic types of HPV is 13 times greater in HIV positive individuals who practiced oral sex with more than one person during the previous year.[2947]

RELATION TO PREGNANCY

Genital warts in pregnancy flourish well with increase in size and number, which is believed to be due to hormonal influence, increased vascularity and relative immune-deficiency. Elective caesarean is advised in case of genital warts as vertical transmission of HPV DNA from an HPV infected mother to a neonate is increased if the infant is delivered through an infected cervix. However the absence of persistent infections infection infants at 6 months after delivery may suggest temporary inoculation rather than true vertical infection.[48] Despite the overwhelming evidence for a sexual transmission of high-risk HPVs, other routes of transmission have been proposed. Several studies have explored whether HPVs can be vertically transmitted from mother to child by direct contact during labor, or horizontally through manipulation of the child with infected hands, bathing, towels and fomites. 19.7% of the 66 infants born to HPV positive mothers and 16.9% of the 77 infants born to HPV-negative mothers tested HPV-DNA positive at some point during follow-up thus Children of mothers’ who were HPV-positive at the post-partum visit are nearly 5 times more likely to test HPV-positive than children of corresponding HPV-negative mothers.[49] The oncogenic HPV types 16, 18, 31, 33 and 35 are common, whereas HPV types 6 and 11 are rarely seen. The interaction between oral HPV and Pregnancy is yet to be studied.

CONCLUSION

Oropharyngeal HPV infection is primarily associated with sexual activities especially oro-genital sex and vertical transmission during birth. High risk sexual behavior of cohabiting numerous partners, particularly when initiated at an early age play a major role in its pathogenesis. HPV infection is more strongly related to couples who practiced oral sex as against couples who solely practiced vaginal sex. Considering the Indian Scenario, no significant data is available regarding the changing trends of sexual practices and its impact on currently prevalent STI's especially HPV infection. The spectrum of manifestations of HPV infection range from focal epithelial hyperplasia, OLP, squamous papilloma to SCC. High level of suspicion for HPV infection in undiagnosed persistent oral lesions especially in high risk group can facilitate diagnosis can facilitate diagnosis [Table 3] of oral HPV.
Table 3

Laboratory investigations

Laboratory investigations Role of HPV in oropharyngeal cancer needs to be evaluated further. The limitation is scarce availability of polymerase chain reaction as a diagnostic technology to pick up oral HPV.
  43 in total

1.  A causal role for human papillomavirus in head and neck cancer.

Authors:  M L Gillison; D R Lowy
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

2.  Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior.

Authors:  Alice Forster; Jane Wardle; Judith Stephenson; Jo Waller
Journal:  J Health Commun       Date:  2010-03

3.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

4.  Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.

Authors:  Nubia Muñoz; Fabián Méndez; Héctor Posso; Mónica Molano; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Muñoz
Journal:  J Infect Dis       Date:  2004-11-22       Impact factor: 5.226

5.  Oral verrucous carcinoma: a study of 12 cases.

Authors:  Alper Alkan; Emel Bulut; Omer Gunhan; Bora Ozden
Journal:  Eur J Dent       Date:  2010-04

6.  [Focal epithelial hyperplasia].

Authors:  Yolanda Delgado; Antonio Torrelo; Isabel Colmenero; Antonio Zambrano
Journal:  Actas Dermosifiliogr       Date:  2005-12

7.  Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

Authors:  Anna R Giuliano; Beibei Lu; Carrie M Nielson; Roberto Flores; Mary R Papenfuss; Ji-Hyun Lee; Martha Abrahamsen; Robin B Harris
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

Review 8.  HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).

Authors:  N Termine; V Panzarella; S Falaschini; A Russo; D Matranga; L Lo Muzio; G Campisi
Journal:  Ann Oncol       Date:  2008-06-16       Impact factor: 32.976

9.  Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery.

Authors:  Hyun Park; Si Won Lee; In Ho Lee; Hyun Mee Ryu; A Reum Cho; Young Soon Kang; Sung Ran Hong; Sung Soon Kim; Seok Ju Seong; Son Moon Shin; Tae Jin Kim
Journal:  Virol J       Date:  2012-04-12       Impact factor: 4.099

10.  Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset.

Authors:  Sara W Dyrstad; Krishna A Rao
Journal:  Clin Med Oncol       Date:  2008-07-18
View more
  7 in total

Review 1.  Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies.

Authors:  Deepa Nair; Manish Mair; Arjun Singh; Anil D'Cruz
Journal:  Indian J Surg Oncol       Date:  2018-09-03

2.  Factors Associated with Attitudes towards Preventing Head and Neck Cancer through HPV Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2021.

Authors:  Wojciech Pinkas; Mateusz Jankowski; Waldemar Wierzba
Journal:  Vaccines (Basel)       Date:  2022-04-18

Review 3.  Verruca vulgaris of the tongue: a case report with a literature review.

Authors:  Ahmet Ural; Selçuk Arslan; Şafak Ersoz; Betül Değer
Journal:  Bosn J Basic Med Sci       Date:  2014-08-16       Impact factor: 3.363

4.  Expression of Human Papillomavirus DNA and p53 Polymorphisms through Polymerase Chain Reaction in Normal Mucosa and Oral Leukoplakia Individuals with Deleterious Oral Habits.

Authors:  Atmakuri Shanmukha Ramya; Sumit Majumdar; T Mahesh Babu; Divya Uppala; Baratam Srinivas; Ayyagari Kameswara Rao
Journal:  Int J Appl Basic Med Res       Date:  2017 Apr-Jun

5.  Rare Report Case of Oral Verruca Vulgaris on Torus Palatinus.

Authors:  Lee Kian Khoo; Low Eng Chai; Bishwa Prakash Bhattarai; Dinesh Rokaya; Boonaur Yongvanichakorn; Natthamet Wongsirichat
Journal:  Eur J Dent       Date:  2021-10-21

Review 6.  Oral Papillomatosis: Its Relation with Human Papilloma Virus Infection and Local Immunity-An Update.

Authors:  Elena Cristina Andrei; Ileana Monica Baniță; Maria Cristina Munteanu; Cristina Jana Busuioc; Garofița Olivia Mateescu; Ramona Denise Mălin; Cătălina Gabriela Pisoschi
Journal:  Medicina (Kaunas)       Date:  2022-08-15       Impact factor: 2.948

7.  High prevalence of human papillomavirus (HPV) in oral mucosal lesions of patients at the Ambulatory of Oral Diagnosis of the Federal University of Sergipe, Northeastern Brazil.

Authors:  Mariana Goveia Melo Ribeiro; Larissa Doddi Marcolino; Bruna Ribeiro de Andrade Ramos; Elaine Alves Miranda; Cleverson Luciano Trento; Sona Jain; Ricardo Queiroz Gurgel; Márcia Guimarães da Silva; Silvio Santana Dolabella
Journal:  J Appl Oral Sci       Date:  2017 Jan-Feb       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.